- Home
- RYN vs ACLX Comparison
RYN vs ACLX Comparison
Compare RYN & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYN
- ACLX
- Stock Information
- Founded
- RYN 1926
- ACLX 2015
- Country
- RYN United States
- ACLX United States
- Employees
- RYN N/A
- ACLX N/A
- Industry
- RYN Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- RYN Real Estate
- ACLX Health Care
- Exchange
- RYN Nasdaq
- ACLX Nasdaq
- Market Cap
- RYN 4.1B
- ACLX 4.1B
- IPO Year
- RYN N/A
- ACLX 2022
- Fundamental
- Price
- RYN $26.10
- ACLX $75.20
- Analyst Decision
- RYN Hold
- ACLX Strong Buy
- Analyst Count
- RYN 4
- ACLX 13
- Target Price
- RYN $28.00
- ACLX $114.75
- AVG Volume (30 Days)
- RYN 915.1K
- ACLX 526.7K
- Earning Date
- RYN 11-05-2025
- ACLX 11-06-2025
- Dividend Yield
- RYN 11.08%
- ACLX N/A
- EPS Growth
- RYN 389.17
- ACLX N/A
- EPS
- RYN 4.92
- ACLX N/A
- Revenue
- RYN $1,239,943,000.00
- ACLX $56,979,000.00
- Revenue This Year
- RYN N/A
- ACLX N/A
- Revenue Next Year
- RYN $4.07
- ACLX $174.18
- P/E Ratio
- RYN $5.30
- ACLX N/A
- Revenue Growth
- RYN 40.53
- ACLX N/A
- 52 Week Low
- RYN $21.84
- ACLX $47.86
- 52 Week High
- RYN $32.88
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- RYN 51.52
- ACLX 59.74
- Support Level
- RYN $26.02
- ACLX $70.11
- Resistance Level
- RYN $26.80
- ACLX $78.61
- Average True Range (ATR)
- RYN 0.47
- ACLX 2.62
- MACD
- RYN -0.11
- ACLX 0.52
- Stochastic Oscillator
- RYN 34.35
- ACLX 70.63
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.